Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

668
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
668
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

70
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
70
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

83
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
83
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

710
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

93
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
93

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction.

Briefings in bioinformatics·2022
Same author

Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection.

Briefings in bioinformatics·2022
Same author

Prediction of potential miRNA-disease associations based on stacked autoencoder.

Briefings in bioinformatics·2022
Same author

Dual-Network Collaborative Matrix Factorization for predicting small molecule-miRNA associations.

Briefings in bioinformatics·2021
Same author

Ensemble of kernel ridge regression-based small molecule-miRNA association prediction in human disease.

Briefings in bioinformatics·2021
Same author

Deep-belief network for predicting potential miRNA-disease associations.

Briefings in bioinformatics·2021
Same journal

Literature-informed gene extraction and ranking for multimodal data fusion.

Briefings in bioinformatics·2026
Same journal

SA-MTP: a structure-aware framework for multifunctional therapeutic peptide annotation.

Briefings in bioinformatics·2026
Same journal

Genome assemblies and annotations are not static and need support for tracking their evolution.

Briefings in bioinformatics·2026
Same journal

A historical journey of metabolite-protein interaction discovery: from data harmonization to AI-driven prediction.

Briefings in bioinformatics·2026
Same journal

Bridging local-global transmembrane protein contexts with contrastive pretraining for alignment-free pathogenicity prediction.

Briefings in bioinformatics·2026
Same journal

Prediction of drug hypersensitivity by comprehensive modeling of HLA-peptidomes.

Briefings in bioinformatics·2026
查看所有相关文章

相关实验视频

Updated: Jun 29, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

药物研究的计算模型

Xing Chen1, Li Huang2

  • 1School of Science, Jiangnan University, Wuxi, 214122, China.

Briefings in bioinformatics
|April 6, 2024
PubMed
概括
此摘要是机器生成的。

本专题号探讨了药物发现的计算模型,涵盖生物活性和相互作用预测,免疫疗法和疾病治疗. 这些计算方法为现代药物研究提供了广泛的视角.

关键词:
计算模型是一种计算模型.药物相互作用 药物相互作用药物研究 药物研究药物治疗 治疗 药物治疗互动 互动 预测 预测

更多相关视频

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

相关实验视频

Last Updated: Jun 29, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

科学领域:

  • 计算机化药物发现.
  • 生物信息学是一种生物信息学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 计算模型在现代药物研究中越来越重要.
  • 存在多种不同的应用,从预测药物特性到设计治疗方法.

研究的目的:

  • 介绍一系列关于药物研究中的计算建模的研究和评论文章.
  • 突出预测药物生物活性和相互作用的进展.
  • 展示免疫疗法和特定疾病治疗的计算方法.

主要方法:

  • 该期刊包括六篇研究文章和四篇复习文章.
  • 方法包括广泛的计算技术.
  • 重点领域包括预测建模和模拟.

主要成果:

  • 这些论文涵盖了各种计算药物研究主题.
  • 关键领域包括药物生物活性预测和药物相关相互作用预测.
  • 免疫疗法和特定疾病治疗的建模也详细说明.

结论:

  • 计算建模为药物研究提供了强大的视角.
  • 该收藏代表了当前研究格局的快照.
  • 这些研究强调了计算在制药科学中的不断扩大的作用.